Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort study
Year: 2024
Type: article
Study design: Observational Study
Source: Annals of the Rheumatic Diseases
Authors: Yasuhiro Katsumata, Eisuke Inoue, Masayoshi Harigai, Jiacai Cho, Worawit Louthrenoo, Alberta Hoi, Vera Golder, Chak Sing Lau, Aisha Lateef, Yi-Hsing Chen, Shue-Fen Luo, Yeong-Jian Jan Wu, Laniyati Hamijoyo, Zhanguo Li, Sargunan Sockalingam, Sandra Navarra, Leonid Zamora, Yanjie Hao, Zhuoli Zhang, Madelynn Chan, Shereen Oon, Kristine Ng, Jun Kikuchi, Tsutomu Takeuchi, Fiona Goldblatt, Sean O'Neill, Nicola Tugnet, Annie Hui Nee Law, Sang-Cheol Bae, Yoshiya Tanaka, Naoaki Ohkubo, Sunil Kumar, Rangi Kandane-Rathnayake, Mandana Nikpour, Eric F Morand
Institutions: Tokyo Women's Medical University, SHOWA Medical University, National University Hospital, Chiang Mai University, Monash Health, Monash University, University of Hong Kong, National University Health System, Taichung Veterans General Hospital, Taichung Armed Forces General Hospital, Chang Gung Memorial Hospital, Chang Gung University, Padjadjaran University, Peking University, Peking University People's Hospital, University of Malaya, University of Santo Tomas Hospital, University of Santo Tomas, The University of Melbourne, St Vincent's Hospital Melbourne, Peking University First Hospital, Tan Tock Seng Hospital, Waitemata District Health Board, Keio University, Saitama Medical University, Repatriation General Hospital, UNSW Sydney, Ingham Institute, Auckland District Health Board, Singapore General Hospital, Hanyang University Seoul Hospital, Hanyang University Hospital for Rheumatic Disease, Hanyang University, University of Occupational and Environmental Health Japan, Middlemore Hospital, The University of Sydney
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Bristol-Myers Squibb, Eli Lilly and Company, AstraZeneca, GlaxoSmithKline, UCB, GlaxoSmithKline Australia, National Research Foundation, Ministry of Education, Culture, Sports, Science and Technology, National Research Foundation of Korea, Japan Society for the Promotion of Science, Janssen Pharmaceuticals
OpenAlex ID: W4392298595